Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.21.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Income Statement [Abstract]        
Revenue $ 559,370 $ 388,654 $ 1,870,306 $ 821,398
Cost of goods sold 955,466 326,671 2,030,447 645,463
Gross profit (loss) (396,096) 61,983 (160,141) 175,935
Operating expenses:        
Research and development 4,165,732 664,145 9,135,410 999,449
Sales and marketing 646,713 304,880 1,873,955 863,400
General and administrative 6,805,788 1,482,018 14,168,782 3,445,749
Total operating expenses 11,618,233 2,451,043 25,178,147 5,308,598
Loss from operations (12,014,329) (2,389,060) (25,338,288) (5,132,663)
Other income (expense):        
Other income, net 12,254 17,503 40,943 17,523
Interest expense (95,469) (2,312) (324,670)
Loss on extinguishment of debt (213,700) (566,925)
Other income (expense), net 12,254 (291,666) 38,631 (874,072)
Net loss (12,002,075) (2,680,726) (25,299,657) (6,006,735)
Deemed dividend on modification of Series H-5 warrants (432,727) (432,727)
Net loss Attributable to Common Stockholders $ (12,002,075) $ (3,113,453) $ (25,299,657) $ (6,439,462)
Net loss per share, basic and diluted $ (0.33) $ (0.13) $ (0.73) $ (0.54)
Basic and diluted weighted average Common Stock outstanding 36,312,478 23,599,967 34,615,858 11,896,906